Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Articles published by Huonslab Co., Ltd.

News headline image
Huonslab Announces Submission of Biologics License Application for Recombinant Human Hyaluronidase ‘HYDIZYME™’
From Huonslab Co., Ltd.
Via Business Wire
News headline image
Huonslab Secures Formulation Patent for Recombinant Human Hyaluronidase Product, HYDIZYME™
From Huonslab Co., Ltd.
Via Business Wire
News headline image
Huonslab Achieves Last-Patient-In (LPI) in Phase 1 Pivotal Study for Recombinant Human Natural Hyaluronidase PH20
From Huonslab Co., Ltd.
Via Business Wire
News headline image
Huonslab Announces Significantly Enhanced Bioavailability of SC Infliximab Co-formulated with HyDIFFUZE™ in Sprague-Dawley Rats; Abstract Selected for Presentation at AACR 2025
From Huonslab Co., Ltd.
Via Business Wire
News headline image
Huonslab Announces Issuance of Process Patent for HyDIFFUZETM Drug Delivery Platform and MFDS IND Clearance for HLB3-002
From Huonslab Co., Ltd.
Via Business Wire
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.